Cargando…
Dexmedetomidine Alleviates Intracerebral Hemorrhage-Induced Anxiety-Like Behaviors in Mice Through the Inhibition of TRPV4 Opening
Post-stroke anxiety severely affects recovery in patients with intracerebral hemorrhage (ICH). Dexmedetomidine (Dex), a highly selective alpha 2 adrenal receptor (α2-AR) agonist, was recently found to exert an excellent protective effect against mental disorders including anxiety. The transient rece...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012538/ https://www.ncbi.nlm.nih.gov/pubmed/35431940 http://dx.doi.org/10.3389/fphar.2022.852401 |
_version_ | 1784687816191508480 |
---|---|
author | An, Ping Zhao, Xiao-Chun Liu, Man-Jia You, Yu-Qing Li, Jing-Ya Gong, He-Song |
author_facet | An, Ping Zhao, Xiao-Chun Liu, Man-Jia You, Yu-Qing Li, Jing-Ya Gong, He-Song |
author_sort | An, Ping |
collection | PubMed |
description | Post-stroke anxiety severely affects recovery in patients with intracerebral hemorrhage (ICH). Dexmedetomidine (Dex), a highly selective alpha 2 adrenal receptor (α2-AR) agonist, was recently found to exert an excellent protective effect against mental disorders including anxiety. The transient receptor potential vanilloid 4 (TRPV4) channel is involved in a series of diseases such as asthma, cancer, anxiety, and cardiac hypertrophy. This study examines whether Dex improved ICH-induced anxiety via the inhibition of TRPV4 channel opening. A rodent model of moderate ICH in the basal ganglia was established using autologous blood injection (20 μl). Mice were treated with Dex (25 μg/kg, intraperitoneal injection) every day for 3 days post-ICH. GSK1016790A (1 μmol/2 μl), an agonist of TRPV4, was administered via the left lateral ventricle. Thirty days post-ICH, post-stroke anxiety was evaluated by elevated plus-maze and open-field tests. Following behavioral tests, superoxide dismutase (SOD), malondialdehyde (MDA), astrocytic activation, and A1-and A2-type astrocytes were determined. Primary astrocytes were exposed to hemin to simulate ICH in vitro. Compared with sham-treated mice, Dex administration ameliorates ICH-induced decreases of distance and time in the open-arm, reduces distance and time in the central zone, increases astrocytic activation and A1-type astrocytes, elevates MDA content, downregulates total SOD contents, and decreases A2-type astrocytes. However, GSK1016790A partially reversed the neuroprotective effects of Dex. In addition, Dex significantly inhibited hemin-induced astrocytic activation in vitro. Dex improves ICH-induced anxiety-like behaviors in mice, and the mechanism might be associated with the inhibition of TRPV4-channel opening. |
format | Online Article Text |
id | pubmed-9012538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90125382022-04-16 Dexmedetomidine Alleviates Intracerebral Hemorrhage-Induced Anxiety-Like Behaviors in Mice Through the Inhibition of TRPV4 Opening An, Ping Zhao, Xiao-Chun Liu, Man-Jia You, Yu-Qing Li, Jing-Ya Gong, He-Song Front Pharmacol Pharmacology Post-stroke anxiety severely affects recovery in patients with intracerebral hemorrhage (ICH). Dexmedetomidine (Dex), a highly selective alpha 2 adrenal receptor (α2-AR) agonist, was recently found to exert an excellent protective effect against mental disorders including anxiety. The transient receptor potential vanilloid 4 (TRPV4) channel is involved in a series of diseases such as asthma, cancer, anxiety, and cardiac hypertrophy. This study examines whether Dex improved ICH-induced anxiety via the inhibition of TRPV4 channel opening. A rodent model of moderate ICH in the basal ganglia was established using autologous blood injection (20 μl). Mice were treated with Dex (25 μg/kg, intraperitoneal injection) every day for 3 days post-ICH. GSK1016790A (1 μmol/2 μl), an agonist of TRPV4, was administered via the left lateral ventricle. Thirty days post-ICH, post-stroke anxiety was evaluated by elevated plus-maze and open-field tests. Following behavioral tests, superoxide dismutase (SOD), malondialdehyde (MDA), astrocytic activation, and A1-and A2-type astrocytes were determined. Primary astrocytes were exposed to hemin to simulate ICH in vitro. Compared with sham-treated mice, Dex administration ameliorates ICH-induced decreases of distance and time in the open-arm, reduces distance and time in the central zone, increases astrocytic activation and A1-type astrocytes, elevates MDA content, downregulates total SOD contents, and decreases A2-type astrocytes. However, GSK1016790A partially reversed the neuroprotective effects of Dex. In addition, Dex significantly inhibited hemin-induced astrocytic activation in vitro. Dex improves ICH-induced anxiety-like behaviors in mice, and the mechanism might be associated with the inhibition of TRPV4-channel opening. Frontiers Media S.A. 2022-04-01 /pmc/articles/PMC9012538/ /pubmed/35431940 http://dx.doi.org/10.3389/fphar.2022.852401 Text en Copyright © 2022 An, Zhao, Liu, You, Li and Gong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology An, Ping Zhao, Xiao-Chun Liu, Man-Jia You, Yu-Qing Li, Jing-Ya Gong, He-Song Dexmedetomidine Alleviates Intracerebral Hemorrhage-Induced Anxiety-Like Behaviors in Mice Through the Inhibition of TRPV4 Opening |
title | Dexmedetomidine Alleviates Intracerebral Hemorrhage-Induced Anxiety-Like Behaviors in Mice Through the Inhibition of TRPV4 Opening |
title_full | Dexmedetomidine Alleviates Intracerebral Hemorrhage-Induced Anxiety-Like Behaviors in Mice Through the Inhibition of TRPV4 Opening |
title_fullStr | Dexmedetomidine Alleviates Intracerebral Hemorrhage-Induced Anxiety-Like Behaviors in Mice Through the Inhibition of TRPV4 Opening |
title_full_unstemmed | Dexmedetomidine Alleviates Intracerebral Hemorrhage-Induced Anxiety-Like Behaviors in Mice Through the Inhibition of TRPV4 Opening |
title_short | Dexmedetomidine Alleviates Intracerebral Hemorrhage-Induced Anxiety-Like Behaviors in Mice Through the Inhibition of TRPV4 Opening |
title_sort | dexmedetomidine alleviates intracerebral hemorrhage-induced anxiety-like behaviors in mice through the inhibition of trpv4 opening |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012538/ https://www.ncbi.nlm.nih.gov/pubmed/35431940 http://dx.doi.org/10.3389/fphar.2022.852401 |
work_keys_str_mv | AT anping dexmedetomidinealleviatesintracerebralhemorrhageinducedanxietylikebehaviorsinmicethroughtheinhibitionoftrpv4opening AT zhaoxiaochun dexmedetomidinealleviatesintracerebralhemorrhageinducedanxietylikebehaviorsinmicethroughtheinhibitionoftrpv4opening AT liumanjia dexmedetomidinealleviatesintracerebralhemorrhageinducedanxietylikebehaviorsinmicethroughtheinhibitionoftrpv4opening AT youyuqing dexmedetomidinealleviatesintracerebralhemorrhageinducedanxietylikebehaviorsinmicethroughtheinhibitionoftrpv4opening AT lijingya dexmedetomidinealleviatesintracerebralhemorrhageinducedanxietylikebehaviorsinmicethroughtheinhibitionoftrpv4opening AT gonghesong dexmedetomidinealleviatesintracerebralhemorrhageinducedanxietylikebehaviorsinmicethroughtheinhibitionoftrpv4opening |